Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • XBI vs GSK✓SelectedUSD · GSKXBI vs GSK performance historyLatest closeAs of-2.73%11/20
Stock and ETF performance explorer

XBI vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+803.1%
GSK return
+159.7%
Excess return
+643.4%
Maximum drawdown
-63.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.7%-0.1%-2.6%-2.7%
7D-6.9%-5.3%-1.6%-4.2%
30D-8.2%-3.7%-4.6%-6.6%
3M-14.2%-7.3%-6.9%-11.1%
6M+6.5%-4.2%+10.8%+8.2%
YTD+15.1%+0.9%+14.2%+12.9%
1Y+23.7%+7.3%+16.4%+17.3%
3Y+92.0%+52.7%+39.2%+44.7%
5Y+15.7%+40.1%-24.4%-10.7%
10Y+115.4%+98.7%+16.7%+31.2%
All+803.1%+159.7%+643.4%+356.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling